|
|
|
|
| LEADER |
01492 am a22002413u 4500 |
| 001 |
49478 |
| 042 |
|
|
|a dc
|
| 100 |
1 |
0 |
|a Elman, Noel
|e author
|
| 100 |
1 |
0 |
|a MIT Materials Research Laboratory
|e contributor
|
| 100 |
1 |
0 |
|a Massachusetts Institute of Technology. Department of Materials Science and Engineering
|e contributor
|
| 100 |
1 |
0 |
|a Noel , Elman
|e contributor
|
| 100 |
1 |
0 |
|a Elman, Noel
|e contributor
|
| 100 |
1 |
0 |
|a Ho Duc, Hong Linh
|e contributor
|
| 100 |
1 |
0 |
|a Cima, Michael J.
|e contributor
|
| 700 |
1 |
0 |
|a Ho Duc, Hong Linh
|e author
|
| 700 |
1 |
0 |
|a Cima, Michael J.
|e author
|
| 245 |
0 |
0 |
|a An Implantable MEMS Drug Delivery Device for Rapid Delivery in Ambulatory Emergency Care
|
| 260 |
|
|
|b Springer Netherlands,
|c 2009-10-19T13:40:56Z.
|
| 856 |
|
|
|z Get fulltext
|u http://hdl.handle.net/1721.1/49478
|
| 520 |
|
|
|a We introduce the first implantable drug delivery system based on MEMS (Micro-Electro-Mechanical-Systems) technology specifically designed as a platform for treatment in ambulatory emergency care. The device is named IRD[superscript 3] (implantable rapid drug delivery device) and allows rapid delivery of drugs. Vasopressin was used as a model drug for in vitro tests as it is a commonly used drug for cardiac resuscitation. Experimental results reveal that the IRD3 provides an effective method for rapid delivery without significant drug degradation. Several medical uses and delivery modalities for IRD3 are proposed.
|
| 546 |
|
|
|a en_US
|
| 655 |
7 |
|
|a Article
|
| 773 |
|
|
|t Biomedical Microdevices
|
